SCHEMBL9640346

SCHEMBL9640346

CCc1cccc(CC)c1NC(=O)NCC1(c2ccccc2)CCCCC1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.56
SMN1; SMN2 Q16637 3/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
NPSR1 Q6W5P4 2/20 0.54
ALDH1A1 P00352 4/20 0.53
GAA P10253 1/20 0.53
TP53 P04637 1/20 0.53
SOAT2 O75908 1/20 0.53
ACAT1 P24752 1/20 0.53
SOAT1 P35610 1/20 0.53
SLC6A4 P31645 1/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
HSD17B10 Q99714 1/20 0.51
CNR1 P21554 1/20 0.51
POLB P06746 1/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9641110 0.99 LMNA (0.57) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9640303 0.93 CNR1 (0.58) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9640381 0.90 SOAT1 (0.66) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9641191 0.88 SOAT1 (0.67) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9641050 0.86 TP53 (0.64) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9640397 0.84 TP53 (0.65) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9641246 0.82 SOAT1 (0.76) LMNASMN1; SMN2L3MBTL1NPSR1TP53
SCHEMBL9818721 0.81 CNR1 (0.63) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1
SCHEMBL9200734 0.81 SOAT1 (0.77) LMNASMN1; SMN2L3MBTL1NPSR1TP53
SCHEMBL9818668 0.81 CNR1 (0.70) LMNASMN1; SMN2L3MBTL1NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0293880-B1 ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC UREA COMPOUNDS WARNER-LAMBERT COMPANY (US) 1992-08-26 EP claimed
EP-0293880-B1 ANTIHYPERLIPIDEMIC AND ANTIATHEROSCLEROTIC UREA COMPOUNDS WARNER-LAMBERT COMPANY (US) 1992-08-26 EP disclosed
US-5015644-A Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds WARNER-LAMBERT COMPANY (US) 1991-05-14 US disclosed
EP-0293880-A1 Antihyperlipidemic and antiatherosclerotic urea compounds WARNER-LAMBERT COMPANY (US) 1988-12-07 EP disclosed